Jenburkt Pharma

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE354A01013
NSEID: JENBURPH
BSEID: 524731
View on NSE | View on BSE

INR

948.40

-8.4 (-0.88%)

BSENSE

Sep 25, 04:01 PM

BSE+NSE Vol: 118

{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "948.40",
    "chg": -8.4,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "956.80",
    "mcapval": "422.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "JENBURPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE354A01013",
    "curr_date": "Sep 25, 04:01 PM",
    "curr_time": "16:52 PM",
    "last_traded_at": "Sep 25, 04:01 PM IST",
    "bse_nse_vol": "118 ",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jenburkt Pharmaceuticals Ltd Falls to 52-Week Low of Rs 940 Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs940-4202647",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JenburktPharmac_priceRelatedfactors_4202647.png",
        "date": "2026-09-23 13:05:04",
        "description": "Despite a recent uptick in profits, Jenburkt Pharmaceuticals Ltd has slipped to a fresh 52-week low of Rs 940 on 23 Sep 2026, reflecting persistent selling pressure amid a challenging market backdrop."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-sell-4202427",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JenburktPharmac_mojoScore_4202427.png",
        "date": "2026-09-23 10:10:04",
        "description": "Jenburkt Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4201565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JenburktPharmac_valuationdot_4201565.png",
        "date": "2026-09-23 08:00:06",
        "description": "Jenburkt Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from a fair to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the evolving price attractiveness of the micro-cap pharmaceutical player by examining key valuation metrics, peer comparisons, and historical performance to provide investors with a comprehensive perspective."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-sell-4191105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JenburktPharmac_mojoScore_4191105.png",
        "date": "2026-09-12 10:10:14",
        "description": "Jenburkt Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 7 August 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with the latest comprehensive analysis."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-sell-4173397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JenburktPharmac_mojoScore_4173397.png",
        "date": "2026-08-28 10:10:23",
        "description": "Jenburkt Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd Forms Death Cross Signalling Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-forms-death-cross-signalling-bearish-trend-4168989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JenburktPharmac_dealthcross_4168989.png",
        "date": "2026-08-25 13:26:02",
        "description": "Jenburkt Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s near-term prospects amid ongoing sector challenges."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jenburkt-pharmaceuticals-ltd-is-rated-sell-4157871",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JenburktPharmac_mojoScore_4157871.png",
        "date": "2026-08-17 10:10:20",
        "description": "Jenburkt Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 7 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Jenburkt Pharmaceuticals Declines 1.34% Amid Mixed Signals and Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-declines-134-amid-mixed-signals-and-margin-pressures-4144295",
        "imagepath": "",
        "date": "2026-08-09 16:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Stock opens strong at Rs.1,090.75 (+1.29%) amid positive market sentiment</p>\n                    <p><strong>5 Aug:</strong> Sharp 5.64% rally to Rs.1,162.05 signalling bullish momentum</p>\n                    <p><strong>6 Aug:</strong> Mixed technical signals emerge despite price volatility</p>\n                    <p><strong>7 Aug:</strong> Quarterly results reveal margin pressures; stock falls 6.44% to Rs.1,062.50</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,076.90</div></div>\n                    <div class=\"stat-item\"><div class=\"..."
      },
      {
        "title": "Jenburkt Pharmaceuticals Reports Decline in Quarterly Financial Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-reports-decline-in-quarterly-financial-performance-amid-margin-pressures-4141831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JenburktPharmac_fintrenddot_4141831.png",
        "date": "2026-08-07 11:00:07",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable reversal in its recent financial trajectory. The company’s latest quarterly results for June 2026 reveal a marked decline in key performance metrics, signalling a shift from previously positive trends to a more challenging operating environment."
      }
    ],
    "total": 540,
    "sid": "134395",
    "stock_news_url": "https://www.marketsmojo.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Intimation Regarding Admission Of Equity Shares Of The Company Under Permitted To Trade Category On National Stock Exchange Of India Limited.",
      "datetime": "22-Sep-2026",
      "details": "Intimation regarding admission of Equity shares of the Company under \" Permitted to trade\" category on National Stock Exchange of India Limited.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Sep-2026",
      "details": "Intimation of closure of trading window of the Jenburkt Pharmaceuticals Limited as per the SEBI(Prohibition of Insider Trading) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "18-Sep-2026",
      "details": "Intimation about Resignation of a Senior Management Personnel of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd has declared <strong>207%</strong> dividend, ex-date: 28 Aug 26",
          "dt": "2026-08-28",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jenburkt Pharmaceuticals Ltd Falls to 52-Week Low of Rs 940 Amid Mixed Financial Signals

2026-09-23 13:05:04

Despite a recent uptick in profits, Jenburkt Pharmaceuticals Ltd has slipped to a fresh 52-week low of Rs 940 on 23 Sep 2026, reflecting persistent selling pressure amid a challenging market backdrop.

Read full news article

Jenburkt Pharmaceuticals Ltd is Rated Sell

2026-09-23 10:10:04

Jenburkt Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Jenburkt Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-09-23 08:00:06

Jenburkt Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from a fair to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the evolving price attractiveness of the micro-cap pharmaceutical player by examining key valuation metrics, peer comparisons, and historical performance to provide investors with a comprehensive perspective.

Read full news article

Jenburkt Pharmaceuticals Ltd is Rated Sell

2026-09-12 10:10:14

Jenburkt Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 7 August 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with the latest comprehensive analysis.

Read full news article

Jenburkt Pharmaceuticals Ltd is Rated Sell

2026-08-28 10:10:23

Jenburkt Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Jenburkt Pharmaceuticals Ltd Forms Death Cross Signalling Bearish Trend

2026-08-25 13:26:02

Jenburkt Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s near-term prospects amid ongoing sector challenges.

Read full news article

Jenburkt Pharmaceuticals Ltd. is Rated Sell

2026-08-17 10:10:20

Jenburkt Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 7 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Jenburkt Pharmaceuticals Declines 1.34% Amid Mixed Signals and Margin Pressures

2026-08-09 16:00:06

Key Events This Week

3 Aug: Stock opens strong at Rs.1,090.75 (+1.29%) amid positive market sentiment

5 Aug: Sharp 5.64% rally to Rs.1,162.05 signalling bullish momentum

6 Aug: Mixed technical signals emerge despite price volatility

7 Aug: Quarterly results reveal margin pressures; stock falls 6.44% to Rs.1,062.50

Week Open

Rs.1,076.90

Read full news article

Jenburkt Pharmaceuticals Reports Decline in Quarterly Financial Performance Amid Margin Pressures

2026-08-07 11:00:07

Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable reversal in its recent financial trajectory. The company’s latest quarterly results for June 2026 reveal a marked decline in key performance metrics, signalling a shift from previously positive trends to a more challenging operating environment.